<\/p>\n
T\u00fcrk Toraks Derne\u011fi ve T\u00fcrkiye Ulusal Alerji ve Klinik \u0130mm\u00fcnoloji Dernekleri taraf\u0131ndan yap\u0131lan ortak yaz\u0131l\u0131 a\u00e7\u0131klamada, ast\u0131m\u0131n akci\u011fer i\u00e7i hava yollar\u0131nda mikrobik olmayan bir t\u00fcr iltihap nedeniyle hava yolu duvar\u0131n\u0131n daralmas\u0131 sonucu ortaya \u00e7\u0131kan kronik bir akci\u011fer hastal\u0131\u011f\u0131 oldu\u011fu ve d\u00fcnyada 350 milyon ki\u015finin ast\u0131m hastas\u0131, her y\u0131l 400 binden fazla ki\u015finin de \u00f6l\u00fcm\u00fcn\u00fcn ast\u0131ma ba\u011fl\u0131 oldu\u011fu ifade edildi.<\/p>\n
“T\u00dc\u0130K taraf\u0131ndan yay\u0131mlanan 2022 y\u0131l\u0131 verileri, solunum sistemi hastal\u0131klar\u0131n\u0131n, y\u00fczde 13,5 ile \u00f6l\u00fcm nedenleri aras\u0131nda \u00fc\u00e7\u00fcnc\u00fc s\u0131rada yer ald\u0131\u011f\u0131n\u0131, bu \u00f6l\u00fcmlerin y\u00fczde 0,3’\u00fcn\u00fcn ast\u0131m nedeniyle ger\u00e7ekle\u015fti\u011fini ortaya koymaktad\u0131r.” bilgisine yer verilen a\u00e7\u0131klamada, ast\u0131m\u0131n tekrarlayan ve ataklar halinde gelen nefes darl\u0131\u011f\u0131, nefes al\u0131p verirken ortaya \u00e7\u0131kan h\u0131r\u0131lt\u0131, h\u0131\u015f\u0131lt\u0131, \u0131sl\u0131k sesi, g\u00f6\u011f\u00fcste bask\u0131 hissi ve \u00f6ks\u00fcr\u00fck gibi belirtilerle kendini g\u00f6sterdi\u011fine dikkat \u00e7ekildi.<\/p>\n
A\u00e7\u0131klamada, ast\u0131m tedavisinin amac\u0131n\u0131n, hastal\u0131\u011f\u0131n yak\u0131nmalar\u0131n\u0131n kontrol alt\u0131na al\u0131nmas\u0131 ve hastan\u0131n ya\u015fam\u0131n\u0131 normale en yak\u0131n \u015fekilde devam ettirmesi oldu\u011fu vurguland\u0131.<\/p>\n
Ast\u0131m ila\u00e7lar\u0131n\u0131n b\u00fcy\u00fck bir k\u0131sm\u0131n\u0131n soluk alma yolu ile kullan\u0131lan ila\u00e7lar oldu\u011fu ve bu yolla daha az yan etkiyle hava yollar\u0131nda istenen tedavi edici etkiyi olu\u015fturdu\u011fu bilgisinin aktar\u0131ld\u0131\u011f\u0131 a\u00e7\u0131klamada, \u015funlar kaydedildi:<\/p>\n
“Ast\u0131m kontrol\u00fcn\u00fc g\u00fc\u00e7le\u015ftiren etkenler aras\u0131nda, ila\u00e7lar\u0131n do\u011fru teknikle ve d\u00fczenli kullan\u0131lmamas\u0131, solunum yolu enfeksiyonlar\u0131, alerjenler, sigara duman\u0131 ve kimyasallar gibi tetikleyicilere maruz kalmak say\u0131labilir.<\/p>\n
Yap\u0131lan \u00e7al\u0131\u015fmalar, hastalar\u0131n ila\u00e7lar\u0131n\u0131 doktorunun \u00f6nerdi\u011fi \u015fekilde kullanmas\u0131n\u0131n, sigaray\u0131 b\u0131rakman\u0131n ve obez hastalar\u0131n kilo vermesinin, sa\u011fl\u0131kl\u0131 ve dengeli beslenmenin, d\u00fczenli egzersiz yapman\u0131n, solunan ortam havas\u0131n\u0131 temiz tutman\u0131n ast\u0131m\u0131n kontrol\u00fcn\u00fc kolayla\u015ft\u0131rd\u0131\u011f\u0131 g\u00f6sterilmi\u015ftir. Bu kontrol\u00fcn sa\u011flanmas\u0131nda ast\u0131m yak\u0131nmalar\u0131n\u0131 artt\u0131ran fakt\u00f6rlerin belirlenmesi, bu fakt\u00f6rlerden korunman\u0131n sa\u011flanmas\u0131 ve d\u00fczenli takip alt\u0131nda tedavinin s\u00fcrd\u00fcr\u00fclmesi \u00f6nem ta\u015f\u0131maktad\u0131r.”<\/p>\n